Clinical Level IV
Blood and Marrow Transplant Program
Hackensack Meridian John Theurer Cancer Center
Caring for an Immunocompromised Bone Marrow Transplant Recipient
Special protocols are required to ensure the safety of patients undergoing bone marrow transplants.
Pembrolizumab Plus Chemo Improves Overall Survival in Resectable Gastric Cancer
Ibrutinib-Venetoclax Combo Elicits Durable Complete Responses in TP53+ MCL
Brentuximab Vedotin Triplet Provides Stronger Survival Signal vs R2 in R/R DLBCL
Durvalumab Plus Chemo Shows Sustained Survival Benefit in Advanced Biliary Tract Cancer